Update on CLL by Dr John Byrd to the Leukemia ... - CLL Support

CLL Support

22,514 members38,671 posts

Update on CLL by Dr John Byrd to the Leukemia & Lymphoma Society on 1st May 2013

AussieNeil profile image
AussieNeilAdministrator
1 Reply

A live telephone/web education program on May 1, 2013 with over 1,500 participants, heard Dr John Byrd from the Ohio State University provide an excellent overview and update on CLL.

There is plenty of wide ranging material covered in a very accessible format that I'm sure will be of interest to many of us.

Presentation:

programs.rmei.com/llscll658...

On the left of the presentation, you can scan through the nearly 30 topics covered to see if anything interests you. Click on selected topic(s) as you have the time/interest.

Transcript - Downloadable for those of us that prefer to read rather than listen/watch. Also easily searchable! You'll need to go to the presentation though, to see the referenced slides.

programs.rmei.com/llscll658...

Q&A session - MP3 file (Quite interesting too if you have 25 minutes)

programs.rmei.com/llscll658...

Neil

Written by
AussieNeil profile image
AussieNeil
Administrator
To view profiles and participate in discussions please or .
Read more about...
1 Reply
zevkalman profile image
zevkalman

Great information. Thanks!

You may also like...

ASH 2013: Dr. John Pagel Discusses Radio-Immune Therapy (RIT) in Chronic Lymphocytic Leukemia (CLL)

that I just posted on my blog http://bkoffman.blogspot.com , Dr. John Pagel out of the Hutch and I...

Leukemia Lymphoma Society Study

CoPay Assistance from LLS (Leukemia & Lymphoma Society) USA

previous Part D insurance would not cover Venclexta \\"Off Label\\" - So if you are facing a copay,...

Dr. Neil Kay: CLL Society Webinar, Just Diagnosed: What Do I Need to Know?

1 PM ET. Find out everything you need to know, from A – Z from Dr. Neil Kay of the Mayo Clinic for...

ASH 2017: Dr. Richard Furman on the importance of MCL-1 in CLL (chronic lymphocytic leukemia)

video on MCL-1 and thought our group might be interested (if not already aware!). From the CLL...